Abstract
Clostridium difficile is an etiological agent of pseudomembranous colitis and antibiotic-associated diarrhea. Adhesion is the crucial first step in bacterial infection. Thus, in addition to toxins, the importance of colonization factors in C. difficile-associated disease is recognized. In this study, we identified Fbp68, one of the colonization factors that bind to fibronectin (Fn), as a manganese-binding protein (KD = 52.70 ± 1.97 nm). Furthermore, the conformation of Fbp68 changed dramatically upon manganese binding. Manganese binding can also stabilize the structure of Fbp68 as evidenced by the increased Tm measured by thermodenatured circular dichroism and differential scanning calorimetry (CD, Tm = 58–65 °C; differential scanning calorimetry, Tm = 59–66 °C). In addition, enhanced tolerance to protease K also suggests greatly improved stability of Fbp68 through manganese binding. Fn binding activity was found to be dependent on manganese due to the lack of binding by manganese-free Fbp68 to Fn. The C-terminal 194 amino acid residues of Fbp68 (Fbp68C) were discovered to bind to the N-terminal domain of Fn (Fbp68C-NTD, KD = 233 ± 10 nm, obtained from isothermal titration calorimetry). Moreover, adhesion of C. difficile to Caco-2 cells can be partially blocked if cells are pretreated with Fbp68C, and the binding of Fbp68C on Fn siRNA-transfected cells was significantly reduced. These results raise the possibility that Fbp68 plays a key role in C. difficile adherence on host cells to initiate infection.
Keywords: Bacteria, Fibronectin, Manganese, Receptor Structure-Function, Receptors, Clostridium difficile, Fbp68, Fibronectin, Manganese-binding Protein, Receptors
Introduction
Clostridium difficile is a Gram-positive, spore-forming anaerobic bacterium that infects people and multiple animal species. Colonization of the gastrointestinal tract may be asymptomatic or cause a variety of disorders, including mild diarrhea, pseudomembranous colitis, and antibiotic-associated diarrhea (1). Recent outbreaks in North America and Europe document the seriousness of C. difficile infection (2). C. difficile toxins, including toxin A, toxin B, and a recently identified toxin, binary ADP-ribosyltransferase toxin C. difficile transferase, are thought to be the primary virulence factors that mediate C. difficile-associated disease (3). Because C. difficile colonizes gastrointestinal tissues and enterocyte-like Caco-2 cells (4, 5), colonization factors are also recognized as important virulence factors of C. difficile. A variety of colonization factors has been identified, including the following: capsule (6); proteolytic enzymes (7, 8); S-layer proteins P36 and P47 (9); adhesins such as SLPA, CCAP6, Fbp68, and 12-kDa protein (4, 9–14); flagellins such as FliC and FliD (15, 16); and GroEL chaperones (17, 18).
Adhesion is the first step in bacterial infection, and several adhesins known as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs)2 contribute to this step (19). MSCRAMMs located on bacterial surfaces mediate adhesion by binding to various extracellular matrices including fibronectin (Fn), laminin, collagen, elastin, and proteoglycan on host surfaces (19). Loss of some of these genes may attenuate virulence, indicating that MSCRAMMs are pivotal mediators of bacterial disease (20). Although a number of MSCRAMMs have been investigated in other bacterial pathogens, only a few clostridial adhesins, such as Fbp68, have been characterized, and the colonization mechanisms of C. difficile are still poorly understood (11).
Manganese-binding proteins are important players in bacterial physiology by participating in cation homeostasis (21), carbon metabolism to promote nutrient acquisition (22), signal transduction (23), resistance to oxidative stress (24), and nutrient-deprived stress (25). In addition, the interaction of some bacterial adhesins and ECM components can be modulated by metal ions such as calcium (26, 27). To date, the ability of manganese to mediate bacterial adhesion has not been reported.
Previously, Fbp68 on the surface of C. difficile was shown to serve as an adhesin by binding to Fn, fibrinogen, and vitronectin (11). Interestingly, antibody to Fbp68 can be detected in sera from patients with C. difficile-associated disease, indicating that Fbp68 can induce a host immune response during C. difficile infection (28). Structural analysis of Fbp68 indicates that it contains eight degenerated repeated sequences and a highly probable α-helical region in amino acids 305–340 (11). In this study, we show that Fbp68 is a manganese-binding protein, that manganese enhances the structural stability of Fbp68, and that manganese is required for Fbp68 binding to Fn. Furthermore, we localized the Fbp68-binding site on Fn to the N-terminal domain (NTD), whereas the fibronectin-binding site on Fbp68 resides in the C-terminal 194 amino acids (Fbp68C). Finally, Fbp68C-NTD interaction was able to mediate the adhesion of C. difficile to Caco-2 cells, indicating that Fbp68 is an important colonization factor contributing to clostridial virulence.
MATERIALS AND METHODS
Bacterial Strains and Cell Culture
C. difficile 630 was used in this study (29). C. difficile was cultivated in prereduced anaerobically sterilized peptone yeast extract broth with glucose (Anaerobe Systems, Morgan Hill, CA). Escherichia coli strains were cultured in Luria-Bertani broth (LB) with appropriate antibiotics (Table 1). Caco2 cells were cultured in Dulbecco minimum essential medium (DMEM) containing 10% fetal bovine serum (Invitrogen) and were grown at 37 °C in a humidified atmosphere with 5% CO2 (30).
TABLE 1.
Strains and plasmids used in this study
| Strain or plasmid | Genotype or characteristic | Refs. or sources |
|---|---|---|
| C. difficile strains | ||
| 630WT | Wild type C. difficile strain | 29 |
| CDΔFbp68102 | 630WTΔfbp68::Linco® | This study |
| CDΔFbp68102/pMTL84151-fbp68 | 630WTΔfbp68::Linco®, complemented with fbp68 | This study |
| E. coli strains | ||
| DH5α | F−Φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK− mK+) supE44 thi-1 gyrA96 relA1λ− | Invitrogen |
| BL21 | F−, ompT, hsdSB (rB−, mB−), dcm, gal, λ(DE3) | Promega |
| M15[pREP4] | nalS strS rifS,S thi−lac−ara−gal+mtl− F−recA+uvr+lon+ [pREP4 KanR] | Qiagen |
| CA434 | F−mcrB mrr hsdS20(rB− mB−) recA13 leuB6 ara−14 proA2 lacY1 galK2 xyl−5 mtl−1 rpsL20(SmR) glnV44 λ−, R702 | 33 |
| Plasmids | ||
| pQE30 | Ampr, His tag protein expression vector | Qiagen |
| pGEX4T2 | Ampr, GST tag protein expression vector | GE Healthcare |
| pQE30-fbp68 | pQE30 carrying intact fbp68 | This study |
| pQE30-fbp68N | pQE30 carrying fbp68N | This study |
| pQE30-fbp68C | pQE30 carrying fbp68C | This study |
| pQE30-ligBCon4 | pQE30 carrying ligBCon4 | 37 |
| pQE30-ligBCen2 | pQE30 carrying ligBCen2 | 36 |
| pGEX4T2-fbp68 | pGEX4T2 carrying fbp68 | This study |
| pGEX4T2-fbp68N | pGEX4T2 carrying fbp68N | This study |
| pGEX4T2-fbp68C | pGEX4T2 carrying fbp68C | This study |
| pGEX4T2-ligBCon | pGEX4T2 carrying ligBCon | 37 |
| pMTL007C-E2 | Cycloseriner, Cefotaxiner; shuttle vector | 31 |
| pMTL007C-E2-CDI-Fbp68–102S | pMTL007C-E2 carrying the intron for target fbp68 102–103S site | This study |
| pMTL84151 | Cefotoxinr, Thiamphenicolr, Cycloseriner; expression vector | 33 |
| pMTL84151-fbp68 | pMTL84151 carrying intact fbp68 | This study |
Gene Knock-out and Characterization of the Mutants
The fbp68 was an insertion knock-out using the ClosTron gene knock-out system developed by Heap et al. (31–33). The intron target sites within fbp68 recognized by L1.LtrB-derived introns were identified by using intron target tool, one of which, 102 bp from the start codon, was used to generate a mutant designated CDΔFbp68102 (Table 1). The intron targeting region designated by the intron design tool was constructed synthetically by DNA 2.0 Inc. (Menlo Park, CA). The synthetic construct was inserting into the ClosTron plasmid pMTL007C-E2, and the resulting plasmid pMTL007C-E2-CDI-Fbp68–102S (Table 1) was electroporated into the conjugative donor E. coli CA434 and then transferred via conjugation into C. difficile 630. Successful transconjugates were selected from a BHI plate supplemented with 250 μg/ml cycloserine (Sigma) and 8 μg/ml cefotaxime (Sigma) to select against the E. coli conjugal donor and 15 μg/ml thiamphenicol (Sigma) to select for the pMTL007C-E2-CDI-Fbp68-102S retargeted C. difficile. Subsequent integrants were selected on BHI agar supplemented with lincomycin (20 μg/ml) (Sigma). PCR using primers that flanked fbp68 and EBS universal primer was performed to demonstrate the integration of L1.LtrB-derived introns (Table 2). PCR using Thio-F1 and ErmB-R1 primers (Table 2) confirmed the Linco® phenotype was caused by the splicing of the group I intron from the group II intron following integration and not a spontaneous Linco® (32). Two primers, FliD-F and FliD-R, were used to demonstrate that the mutant is a C. difficile strain (Table 2). The PCR product of fbp68 using primers Fbp68F and Fbp68R (Table 2) was inserted into plasmid pMTL84151 (Table 1), electroporated into the conjugative donor E. coli CA434, and then transferred via conjugation into CDΔFbp68102 for complementary testing as described previously (33).
TABLE 2.
Oligonucleotides used in this study
| Primer/vector | Sequence |
|---|---|
| fbp68-Fa | CCGGAATTCATGGCATTAGATGGATTAGTTATAC |
| fbp68-Ra | CGCGGATCCTTATTCAGATTTAACCTTAAGCTTGG |
| EBS:Universala | CGAAATTAGAAACTTGCGTTCAGTAAAC |
| ErmB-R1a | GAACGCGTGCGACTCATAGAATTATTTCCTCCCG |
| Thio-F1a | CTACTAGTACGCGTTATATTGATAAAAATAATAATAGTGGG |
| fliD-Fa | CATATGATGTCAAGTATAAGTCCAGTAAG |
| fliD-Ra | TTAATTACCTTGTGCTTGTGAG |
| Fbp68fp | CGGGATCCGCATTCGATGGA |
| Fbp68rp | CGGTCGACTTATTCAGATTTAACCTT |
| Fbp68Nfp | CGGGATCCGCATTCGATGGA |
| Fbp68Nrp | CGGTCGACCTTTTTAAAGTATTTTTG |
| Fbp68Cfp | CGGGATCCTATAACAAAATGAAACAT |
| Fbp68Crp | CGGTCGACTTATTCAGATTTAACCTT |
a Primers used for mutant generation.
Reagents and Antibodies
Fibronectin (human plasma fibronectin), NTD, or gelatin binding domain of Fn, EDTA, sodium chloride, sodium phosphate monobasic, sodium phosphate dibasic, Tris, magnesium chloride, manganese chloride, zinc chloride, calcium chloride, protease K, and protein A-10 nm gold particle colloidal suspension were purchased from Sigma. 120-kDa cell binding domain (CBD) or 40-kDa domain of Fn, mouse anti-fibronectin, and mouse anti-α-actin were purchased from Chemicon International (Temecula, CA). Fbp68 antibody was prepared by vaccination of rabbits. Briefly, intramuscular inoculation with 100 μg of recombinant Fbp68 in Freund's complete adjuvant (first vaccination) was followed by 100 μg intramuscularly in Freund's incomplete adjuvant (booster) 3 weeks later. Three weeks after the second booster, the rabbit was sacrificed, and serum was collected. Anti-C. difficile antibodies were previously prepared by vaccination of horses with whole killed cells of C. difficile. Mouse anti-histidine tag, rabbit anti-GST antibody, Texas Red-conjugated goat anti-rabbit IgG, FITC-conjugated goat anti-horse antibody, FITC-conjugated goat anti-mouse antibody, HRP-conjugated goat anti-mouse antibody, and HRP-conjugated goat anti-rabbit antibody were ordered from Invitrogen. HRP-conjugated goat anti-horse antibody was purchased from KPL (Gaithersburg, MD).
Plasmid Construction and Protein Purification
The construct for the expression of histidine tag fused with Fbp68, GST, and histidine tag fused with Fbp68N (amino acids 2–396) or Fbp68C (amino acids 397–591) was generated using vectors pQE30 (Qiagen, Valencia, CA) and pGEX4T2 (GE Healthcare) (Fig. 1A). To perform the PCRs, the primers shown in Table 2 were utilized based on the Fbp68 sequence (11). Primers were engineered to introduce a BamHI site at the 5′ end of each fragment and a stop codon followed by a SalI site at the 3′ end of each fragment. PCR products were sequentially digested with BamHI and SalI and then ligated into pQE30 or pGEX4T2 cut with BamHI and SalI, respectively. The soluble forms of all of recombinant proteins were purified from E. coli as described previously (34, 35).
FIGURE 1.
Schematic presentation of Fbp68 and Fn used in this study. A, schematic diagram showing the structure of Fbp68 and the truncated Fbp68 proteins Fbp68N (residues 2–396) and Fnbp68C (residues 397–591) used in this study. B, chart representing fibronectin (Fn) and truncated Fn including N-terminal domain (NTD), gelatin binding domain (GBD), cell binding domain (CBD, 70 kDa domain), and 40 kDa domain (heparin-binding domain plus Fn15) in this study.
Isothermal Titration Calorimetry (ITC)
The experiments were carried out with a CSC 5300 microcalorimeter (Calorimetry Science Corp., Lindon, UT) at 25 °C as described previously (26). Before the ITC experiment, traces of metal ions were removed from Fbp68 solution through incubation with EDTA and subsequent dialysis in Tris buffer (25 mm Tris, 150 mm sodium chloride (pH 7.0)). The cell contained 1 ml of a solution of Fbp68, and the syringe contained 250 μl of a solution of various metal ions at different concentrations, as indicated in Table 3. For the NTD binding experiments, 1 ml of NTD (35 μm) was in the cell, and 250 μl of Fbp68C (325 μm) with 100 μm of MnCl2 were in the syringe. All solutions were in Tris buffer (pH 7.0). The concentration of each species is presented in Table 3. The titration was performed as follows: 25 injections of 10 μl with a stirring speed of 250 rpm with a delay time between injections of 5 min. Data were analyzed using BindWorks software (model CSC 5300, Calorimetry Science Corp.) fitting them to an independent binding model.
TABLE 3.
Thermodynamic parameters for the interaction of metal ions and Fbp68
| Metal ion | [Metal ion] | [Fbp68] | ΔH | TΔS | KD | ΔG | n |
|---|---|---|---|---|---|---|---|
| μm | μm | kcal mol−1 | kcal mol−1K−1 | nm | kcal mol−1 | Metal ion:Fbp68 | |
| Mn2+ | 1000 | 38 | −12.14 ± 0.05 | −2.25 ± 0.02 | 52.70 ± 1.97 | −9.88 ± 0.02 | 4.98 ± 0.02 |
| Ca2+ | 1000 | 42 | NFa | NF | NF | NF | NF |
| Mg2+ | 1000 | 31 | NF | NF | NF | NF | NF |
| Zn2+ | 1000 | 49 | NF | NF | NF | NF | NF |
a NF means not fitted.
Fluorescence Spectrometry
Fbp68 was treated with 50 μm of EDTA and then extensively dialyzed in Tris buffer (pH 7.0) to remove metal ions. Fluorescence emission spectra were measured on a Hitachi F7500 spectrofluorometer (Hitachi, San Jose, CA). All spectra were recorded in the correct spectrum mode of the instrument using excitation and emission band passes of 5 nm. The intrinsic Trp fluorescence of protein was recorded by exciting the solution at 295 nm and measuring the emission in the region from 305 to 400 nm. For manganese titration, 0, 25, 50, 100, 200, and 400 nm manganese chloride were mixed with 1 μm Fbp68. and spectra were recorded after 3 min.
For the ANS fluorescence experiment, ANS binding was checked by adding 100 μm ANS solution (10 mm stock in 100% methanol) to a protein solution (1 μm) and incubated for 2 min, and spectra were recorded between 400 and 600 nm. Next, Fbp68 was treated with different concentrations of MnCl2 (0, 25, 50, 100, 200, and 400 nm) for 5 min, and then spectra were measured at an excitation wavelength of 295 nm. All spectra were recorded in the correct spectrum mode with excitation and emission band passes of 5 nm each and corrected for volume changes before further analysis. All measurements were performed at 25 °C.
CD Spectrometry
CD spectra were recorded on a Jasco J-815 spectropolarimeter under N2 atmosphere at room temperature (25 °C) in 0.02- and 0.5-cm path length quartz cells for far- and near-UV, respectively, with eight repeated measurements. The Fbp68 was treated with 50 μm EDTA and then extensively dialyzed in Tris buffer (pH 7.0) to remove metal ions. Aliquots of manganese chloride solution (0, 25, 50, 100, 200, and 400 nm) were added to 1 μm Fbp68 protein solution and incubated for 5 min. All spectra were recorded in Tris buffer (pH 7.0). In a melting temperature experiment, 10 μm Fbp68 in the absence or presence of 100 μm MnCl2 was subjected to thermal unfolding, and data were collected at 1 °C/min increments from 25 to 100 °C recording the ellipticity at 205 nm, with 30-s temperature equilibrations, followed by 30 s of data averaging. To measure the melting point, a first order derivative was applied to the results from the melting experiment. In all CD experiments, the background spectrum of Tris buffer (pH 7.0) alone was subtracted from the protein-containing spectra.
Differential Scanning Calorimetry (DSC)
Excess heat capacity Cp(T) of Fbp68C with or without MnCl2 was measured using a DSC Q1000 microcalorimeter (Waters). The Fbp68 was treated with 50 μm EDTA and then extensively dialyzed in Tris buffer (pH 7.0) to remove metal ions. Degassed sample containing 30 μm Fbp68 with or without 100 μm MnCl2 in Tris buffer were heated at 0.1 K/min scan rate. Heat capacity, Cp(T), data were recorded, corrected for buffer base line, and normalized to the amount of the sample. The TA Universal Analysis software (Waters) was used for the data analysis and display. All calorimetric experiments in this study were repeated three times to ensure reproducibility.
Protease K Resistance Experiment
The recombinant histidine-tagged Fbp68 used in this study was treated with 50 μm EDTA and subsequently dialyzed in Tris buffer (pH 7.0) to remove trace metal ions. One μm Fbp68 was mixed with or without 100 μm MnCl2 and then dialyzed in Tris buffer to remove the unbound MnCl2 to prevent unbound MnCl2 from interfering with the activity of protease K. Then Fbp68 samples with and without MnCl2 were analyzed for the sensitivity of protease K by treating with 0–60 ng/μl protease K (PK) at 37 °C for 1 h. The reaction was stopped by adding 1 μl of protease inhibitor without EDTA (Thermoscientific, Logan, UT) and then mixing with Laemmli sample loading buffer consisting of 50 mm Tris-HCl (pH 6.8), 100 mm dithiothreitol, 2% SDS, 0.25 mm PMSF, and 0.1% bromphenol blue in 20% glycerol. The digested Fbp68 was subjected to 10% SDS-PAGE and electroblotted onto polyvinylidene difluoride membranes. The membranes were incubated in 5% skim milk in PBS/T overnight and then incubated with mouse anti-histidine tag antibody (1:1000). The immunocomplexes were detected with an HRP-conjugated goat anti-mouse IgG antibody (1:5000).
Binding Assays by ELISA
To determine the binding of untreated or manganese-treated Fbp68 to Fn (Fig. 4A), 100 μl of 1 μm Fn or BSA (negative control and data not shown) were coated on microtiter plate wells and blocked subsequently as described previously (36). Various concentrations of 100 μm MnCl2-treated histidine-tagged LigBCen2 (a known Fn-binding protein from Leptospira interrogans to serve as positive control) (36), untreated or 100 μm MnCl2-treated histidine tagged Fbp68, or LigBCon4 (a protein from L. interrogans lacking Fn binding activity to serve as negative reference) (37) in 100 μl of Tris buffer (pH 7.0) were added to microtiter plate wells and incubated for 1 h at 37 °C. To map the binding sites of Fn on Fbp68 (Fig. 5A), different concentrations of 100 μm MnCl2-treated GST-fused Fbp68 (positive control), LigBCon (a protein from L. interrogans lacking Fn binding activity to serve as negative control) (37), Fbp68N, or Fbp68C in 100 μl of Tris buffer (pH 7.0) were added to microtiter plate wells and incubated for 1 h at 37 °C. To localize the Fbp68C-binding sites on Fn (Fig. 5B), 100 μl of 1 μm Fn (positive control), NTD, gelatin binding domain, CBD, 40-kDa protein, or BSA (negative control) were coated on microtiter plate wells and blocked subsequently as described above. Serial concentrations of 100 μm MnCl2-treated GST-fused Fbp68C or LigBCon (negative reference and data not shown) in 100 μl of Tris buffer (pH 7.0) were added into microtiter plate wells and incubated for 1 h at 37 °C. To detect the binding of Fbp68C to Caco-2 cells (Fig. 7A), 100 μl of 10 μm GST-fused Fbp68C or GST (negative control) was added to microtiter plate wells cultured with 105 Caco-2 cells for 1 h. To determine the inhibitory effect on C. difficile adhesion caused by pretreatment of Fbp68C (Fig. 7B), 105 Caco-2 cells were treated with 100 μl of 10 μm GST-fused Fbp68C or GST (negative reference) at 37 °C for 1 h prior to incubation with 107 C. difficile at 37 °C for 1 h.
FIGURE 4.
Manganese is required for Fbp68 binding to Fn. A, Fn binding to Fbp68 assayed by ELISA. Binding of Fbp68, LigBCen2, or LigBCon4 in the absence of Mn2+ or in the presence of varying concentrations of Mn2+ (1.0, 0.5, 0.25, 0.125, 0.062, 0.037, 0.015, and 0 μm) to immobilized NTD or BSA (negative control and data not shown). 10 nm histidine-tagged LigBCen2 (positive control) and 100 μm manganese-bound or free forms of Fbp68 or LigBCon4 (negative control) were added to a serial dilution of NTD or BSA-coated wells. Bound proteins were estimated by ELISA. Each value represents the mean ± S.E. of three trials in triplicate samples. Statistically significant differences (p < 0.05) are indicted by *. B, SPR analysis of Fbp68 interacting with Fn. 1.5 μm of recombinant histidine-tagged Fbp68 was immobilized on the surface of a NTA chip. 1 μm Fn in Tris buffer in the presence or absence of 100 μm MnCl2 (pH 7.0) flowed through the chip. C, determination of KD of manganese-bound Fbp68 and Fn by SPR analysis. 1.5 μm recombinant histidine-tagged Fbp68 was immobilized on the surface of NTA chip. Fn flowed through the chip in Tris buffer (pH 7.0), and the concentrations of Fn ranged from 1000 to 62.5 nm (from top to bottom). The KD, kon, and koff values were obtained from the average of duplicate experiments (kon = 1.09 ± 0.35 × 104 s−1 m−1; koff = 2.48 ± 0.52 × 10−3 s−1; KD = 228 ± 20 nm).
FIGURE 5.
Fbp68C binds to NTD of Fn. A, binding of serial concentrations of Fbp68, Fbp68N, or Fbp68C to immobilized Fn by ELISA. Serial concentrations of GST-Fbp68N, GST-Fbp68C, GST-Fbp68 (positive control), or GST-LigBCon (negative control) were added to wells coated with 1 μm of Fn or BSA (negative control, data not shown). B, binding of serial concentrations of Fbp68C to immobilized Fn by ELISA. Serial concentrations of GST-Fbp68C or GST-LigBCon (negative control, data not shown) were added to microtiter plate wells coated with 1 μm of Fn, NTD, GBD, CBD, 40 kDa, or BSA (negative control). Bound proteins were measured by ELISA. C, determination of binding affinity by ITC. The cell contained 1 ml of NTD, and the syringe contained 250 μl of Fbp68C (upper panel). Heat differences were obtained from 25 injections of Fbp68C; lower panel, integrated curve with experimental data (♢) and the best fit (—). The thermodynamic parameters are shown in Table 3. The thermodynamic parameters are shown as the average of duplicate experiments (KD = 233 ± 10 nm; ΔH = −5.95 ± 0.38 kcal mol−1; TΔS = 3.05 ± 0.6 kcal mol−1 K−1; n = 0.98 ± 0.02). D, SPR analysis of Fbp68C and NTD. 1.5 μm recombinant histidine-tagged Fbp68C was immobilized on the surface of a Ni-NTA chip. NTD flowed through the chip in Tris buffer (pH 7.0), and the concentrations of NTD ranged from 1000 to 62.5 nm (from top to bottom). The KD, kon, and koff values were obtained from the average of duplicate experiments (kon = 1.23 ± 0.25 × 104 s−1 m−1; koff = 2.66 ± 0.05 × 10−3 s−1; KD = 216 ± 56 nm).
FIGURE 7.
Fn and Caco-2 cell binding activities of Fbp68C and different C. difficile strains. A, binding of Fbp68C to Caco-2 cells. A series concentration (0, 0.015, 0.03125, 0.0625, 0.125, 0.25, 0.5, or 1 μm) of GST-Fbp68C or GST (negative control) was added to Caco-2 cells (105). The binding of each of these proteins to Caco-2 cells was measured by ELISA. B, Fbp68C inhibits the binding of C. difficile to Caco-2 cells. Caco-2 cells were incubated with a series concentration (0, 0.015, 0.03125, 0.0625, 0.125, 0.25, 0.5, or 1 μm) of GST-Fbp68C or GST (negative control) prior to the addition of C. difficile (107). The adhesion of C. difficile to Caco-2 cells (105) was detected by ELISA. The reduced percentage of attachment was determined relative to the attachment of C. difficile to untreated Caco-2 cells. C, Fbp68C inhibits the binding of C. difficile to Caco-2 cells. Caco-2 cells (106) were pretreated with 50 μm GST-Fbp68C or GST (negative control) prior to the addition of C. difficile (108). The adhesion of C. difficile or the binding of these proteins to Caco-2 cells were detected by CLSM. D and E, Fn and cell binding activity of wild type C. difficile (CD630WT), fbp68 mutant (CDΔFbp68102), or fbp68 complemented strain (CDΔFbp68102/pMTL84151-fbp68). D, a total of 108 CD630WT, CDΔFbp68102, or CDΔFbp68102/pMTL84151-fbp68 were added to Fn-coated wells (1 μm/well). The wells coated with 1 μm BSA served as the negative control. Three CLSM fields were selected to count the number of bacteria that were bound to the Fn and BSA coated wells to determine the Fn binding activity of various genotypes of C. difficile as described under “Materials and Methods.” E, a total of 108 cells of CD630WT, CDΔFbp68102, or CDΔFbp68102/pMTL84151-fbp68 were incubated in wells cultured with 106 Caco-2 cells. The wells incubated without Caco-2 cells served as the negative control. Cell binding activity was measured by the bacterial attachment assay as described under “Materials and Methods”; results are shown as the number of cell-associated bacteria per well. A, B, D, and E, each value represents the mean ± S.E. of three trials in triplicate samples. Statistically significant differences (p < 0.05) are indicted by asterisk. C, CLSM settings were identical for all the captured images. Images were processed using Adobe Photoshop CS2.
To detect the binding of histidine-tagged Fbp68, LigBCen2, LigBCon, mouse anti-histidine tagged (1:200), and HRP-conjugated goat anti-mouse IgG (1:1000) were used as primary and secondary antibodies, respectively (34, 35). To measure the binding of GST-fused LigBCon, Fbp68, Fbp68N, Fbp68C, rabbit anti-GST (1:200), and HRP-conjugated goat anti-rabbit IgG (1:1,00) were used as primary and secondary antibodies, respectively. To determine the adhesion of C. difficile, horse anti-GST (1:200) and HRP-conjugated goat anti-horse IgG (1:1000) were used as primary and secondary antibodies, respectively. After washing the plates three times with TBST (0.05% Tween 20 in Tris buffer), 100 μl of TMB (KPL) was added to each well and incubated for 5 min. The reaction was stopped by adding 100 μl of 0.5% hydrofluoric acid to each well. Each plate was read at 630 nm using an ELISA plate reader (BioTek EL-312, Winooski, VT). Each value represents the mean ± S.E. of three trials in triplicate samples. Statistically significant (p < 0.05) differences are indicated by an asterisk.
Bacterial Attachment Assay
To study the adhesion of C. difficile 630 (wild type), CDΔFbp68102(mutant), and CDΔFbp68102/pMTL84151-fbp68 (complemented mutant) to Caco-2 cells (Fig. 7E), an attachment assay was slightly modified from the method reported previously (38). Basically, ice-cold PBS buffer was used to wash the cells prior to the assay to prevent C. difficile invasion. A total of 108 CD630WT, CDΔFbp68102, or CDΔFbp68102/pMTL84151-fbp68 bacteria suspended in ice-cold medium was then incubated with 106 Caco-2 cells at 4 °C for 1 h. The wells incubated without Caco-2 cells served as negative controls. Unattached bacteria were removed by five washes with PBS. PBS containing 1% (v/v) Triton X-100 was used to resuspend adherent bacteria, and the 104-fold dilution of the adherent bacterial suspensions was spread on C. difficile agar plates (BD Biosciences) to determine the number of cell-associated bacteria per well.
Surface Plasmon Resonance (SPR)
The Fbp68-Fn or Fbp68C-NTD interaction was analyzed by an SPR technique using a Biacore 2000 instrument (GE Healthcare). Briefly, Fbp68 and Fbp68C were treated with 50 μm EDTA and subsequently dialyzed in Tris buffer (pH 7.0) to remove trace metal ions. To determine the Fn binding activity of Fbp68 in the presence or absence of manganese (Fig. 4B), 100 μm manganese chloride in Tris buffer (pH 7.0) was mixed with 1.5 μm histidine-tagged Fbp68 when immobilized on an NTA chip (GE Healthcare). Then 10 μl of 1000 nm Fn was injected into the flow cell at 10 μl/min at 25 °C. To measure the binding affinity of Fbp68C and Fn (Fig. 5E), 1.5 μm histidine-tagged Fbp68C was incubated with Tris buffer with or without 100 μm manganese chloride when immobilized on an NTA chip, and the NTA chip was conjugated to 500 μm nickel sulfate prior to the immobilization of Fbp68 or Fbp68C. A control flow cell was injected with Tris buffer without Fbp68 or Fbp68C. Then 10 μl of a serial concentration (0, 62.5, 125, 250, 500, and 1000 nm) of NTD was injected into the flow cell at 10 μl/min at 25 °C. All sensorgram data were subtracted from the negative control flow cell. To obtain the kinetic parameters of the interaction, the data of the sensograms were fitted by BIAevaluation software version 3.0 using the one-step biomolecular association reaction model (1:1 Langmuir model), which resulted in optimum mathematical fits with the lowest χ values.
Binding Assays by Confocal Laser-scanning Microscopy (CLSM)
To determine the binding inhibition of C. difficile to Caco-2 cells by Fbp68C by CLSM, 106 Caco-2 cells were preincubated with 50 μm GST-Fbp68C or GST (negative control) in 100 μl of PBS for 1 h at 37 °C. Then 108 C. difficile 630 was added to each well and incubated for 1 h at 37 °C (Fig. 7C). To measure the adhesion of C. difficile to Fn (Fig. 7D), 108 wild type C. difficile (CD630WT), fbp68 knock-out mutant (CDΔFbp68102), or fbp68 knock-out mutant complemented with intact fbp68 (CDΔFbp68102/pMTL84151-fbp68) was added to glass slides in 24-well plates coated with 1 μm Fn. BSA-coated slides served as negative controls. To determine the attachment of C. difficile and the binding of GST-Fbp68C or GST to Caco-2 cells (Fig. 7, C and D), rabbit anti-GST (1:250) and horse anti-C. difficile antibodies (1:100) served as primary antibodies, and Texas Red-conjugated goat anti-rabbit IgG (1:250) and FITC-conjugated goat anti-horse IgG (1:250) were used as secondary antibodies. Fixation and immunofluorescence staining were performed as described previously (36) with slight modifications. Briefly, C. difficile and Caco-2 cells were fixed in 2% paraformaldehyde for 60 min at room temperature. For antibody labeling, fixed bacteria were incubated in PBS containing 0.3% BSA for 10 min at room temperature. The primary and secondary antibodies in PBS containing 0.3% BSA were incubated sequentially for 60 min at room temperature. After incubation with primary and secondary antibodies, the glass slides were mounted with coverslips using Prolong Antifade (Molecular Probes, Eugene, OR) and viewed with a 60× objective by CLSM (Olympus, America, Inc., Melville, NY). An Olympus Fluoview 500 confocal laser-scanning imaging system equipped with krypton, argon, and He-Ne lasers on an Olympus IX70 inverted microscope with a PLAPO 60× objective was used. The settings were identical for all captured images. Images were processed using Adobe Photoshop CS2. For counting the attachment of C. difficile to Fn-coated wells, three fields (40× objective) were selected at random to count the number of bound organisms. All studies were repeated three times, and the attachment of C. difficile to Caco-2 cells was scored by an operator who was blinded to the treatment group.
Small Interfering RNA (siRNA) Inhibition of Fbp68C Binding
siRNA duplexes directed against human Fn (Ambion AM121357) and negative siRNA duplex (Ambion AM4611) were purchased from Ambion (Foster City, CA). RNA duplexes were introduced into Caco-2 cells by the method of lipofection (37), and 8 × 105 cells were transfected with 0.4 μg of negative siRNA and Fn-siRNA. Adhesion assays were performed 72 h after lipofection (37). The knockdown efficiency of endogenous Fn expression was determined as described previously (37) with slight modification. The total protein content of 106 Caco-2 cells was analyzed using Western immunoblotting as described under “protease K resistance experiments.” The protein bands of actin derived from Caco-2 cells were measured as a control using a mouse anti-actin antibody (1:5000). The band intensity was measured by densitometry using ImageJ software (National Institutes of Health, Bethesda) (39). Fbp68C binding assay was performed 72 h after lipofection. To determine the binding of Fbp68C to Fn, 100 μl of 50 μm GST-Fbp68C or GST was added to 106 Caco-2 cells transfected with Fn or negative siRNA. To determine the binding of Fbp68C and the expression of Fn on Caco-2 cells, rabbit anti-GST (1:250) and mouse anti-Fn (1:250) served as the primary antibodies, and FITC-conjugated goat anti-mouse IgG (1:250) and Texas Red-conjugated goat anti-rabbit IgG (1:250) were used as secondary antibodies. Fixation, immunofluorescence staining, image detection, and processing were as described above. All the experiments were performed in triplicate.
Statistical Analysis
Each data point represents the means ± S.E. for each sample tested in triplicate. Data were analyzed by Student's t test, and statistically significant differences were claimed at p values < 0.05.
RESULTS
Manganese Binds to Fbp68 and Induces Conformational Change
Previously, Fbp68 was identified as a Fn-binding protein (11). Because metal ions can modulate the ECM binding activities of some ECM-binding proteins (26, 27, 40–42), the binding activity of Fbp68 to Ca2+, Mg2+, Zn2+, and Mn2+ was examined in this study through ITC. As shown in Fig. 1A and Table 3, Fbp68 bound to Mn2+ (KD = 52 ± 1.97 nm) but not to Ca2+, Mg2+, or Zn2+, and the stoichiometric values indicated that five manganese ions were able to bind to one Fbp68 (Table 3). Furthermore, a significant quenching of tryptophan fluorescence spectra for Fbp68 (12%) upon Mn2+ binding indicated manganese binding could also alter the conformation of Fbp68 (Fig. 2B). Interestingly, the Fbp68 conformational changes upon Mn2+ binding were mainly in the random coiled region because the proportion of α-helix increased whereas that of random coil was reduced when Fbp68 titrated with Mn2+ was measured through far-UV CD spectrometry (α-helix from 56 to 69%, β-strand remaining at 25%, and random coil from 19 to 6%.) (Fig. 2C). In addition, the conformational change occurred in a hydrophobic area because the fluorescence of ANS-Fbp68 increased dramatically (20%) upon Mn2+ binding (Fig. 2D).
FIGURE 2.
Manganese binds to Fbp68 and induces conformational change. A, binding affinity determined by the ITC profile of Fbp68 with manganese chloride. The heat change obtained with ligand (Mn2+) titration is shown in the upper panel. In the lower panel, the solid lines represent the best fits to a single-site binding model after peak (♢) integration, subtraction of blank titration data (data not shown), and concentration normalization. Molar heats of binding are plotted versus the molar ratio of Mn2+ to protein. Binding potency of protein with ligand (KD) is 52.70 ± 1.97 nm. The thermodynamic data that were obtained from ITC are shown in Table 3. B, intrinsic fluorescence spectrum of Fbp68 in the presence and absence of Mn2+. 1 μm Fbp68 in Tris buffer (pH 7.0) was excited at 295 nm. C, fluorescence emission spectra of ANS-Fbp68 complex in the presence of 0, 12.5, 25, 50, 100, or 200 nm of manganese chloride. The excitation wavelength was set at 375 nm. The buffer consisted of 25 mm Tris (pH 7.0), 150 mm NaCl. D, far-UV CD spectra of Fbp68 were recorded in the presence of manganese. Protein concentration was 1 μm in Tris buffer (pH 7.0). Spectra were recorded with a 0.02-cm path length cuvette. Aliquots of calcium chloride solution were added to a final concentration of 0, 12.5, 25, 50, 100, or 200 nm to the protein solution and CD spectra recorded. Manganese chloride was added to achieve final concentrations of 0, 12.5, 25, 50, 100, or 200 nm. B–D, direction of arrows indicates increasing order of manganese addition.
Manganese Binding Enhances the Stability of Fbp68
The function of Mn2+ binding is generally recognized as maintaining protein stability (43, 44). To gain more insight about the function of manganese binding to Fbp68, DSC thermo-unfolding and thermo-denatured CD were performed. As shown in Fig. 3A, the CD profiles of heat-induced folding to unfolding transition in Mn2+-bound Fbp68 shifted to a significantly higher temperature compared with the apo-Fbp68, and the Tm value of Mn2+-bound Fbp68 also dramatically increased (apo-Fbp68, Tm = 58.0 ± 2.1 °C; Mn2+-bound Fbp68, Tm = 65.9 ± 1.3 °C). A similar result was also observed in the DSC experiment (apo-Fbp68, Tm = 59.3 ± 2.1 °C; Mn2+-bound Fbp68, Tm = 66.1 ± 3.2 °C) (Fig. 3B). It has also been reported that Mn2+-bound proteins can better resist protease digestion compared with apoproteins. Therefore, protease K resistance assays were applied to Mn2+-bound or apo-Fbp68 to test their stability. As indicated in Fig. 3C, Mn2+-bound Fbp68 was able to tolerate a higher concentration of protease K because the decomposition of Mn2+-bound Fbp68 could not be observed until the addition of 60 ng/μl protease K. However, apo-Fbp68 was vulnerable to protease K digestion at a comparatively lower concentrations of protease K (7.5 ng/μl) (Fig. 3C).
FIGURE 3.
Manganese binding stabilizes the structure of Fbp68. A, thermal unfolding transitions of Fbp68 with or without manganese monitored by CD. Unfolding of 10 μm Fbp68 either in the presence or absence of 100 μm manganese chloride was followed by CD, measuring ellipticity at 205 nm from 25 to 70 °C. A transition point was found in both manganese-bound and free forms of protein. The melting temperatures were determined by the location of the peak in the plot of the derivative of ellipticity versus temperature. The midpoints of transitions for manganese-bound or free form of the protein are 65.9 ± 1.3 and 58.0 ± 2.1 °C, respectively. B, molar heat capacity (kcal/(mol·K)) was plotted against the temperature (°C) for thermal denaturation of 30 μm of Fbp68 in the absence or in the presence of manganese chloride (100 μm) as monitored by DSC. Transitions occur with midpoint temperatures of 66.1 ± 3.2 and 59.3 ± 2.1 °C for manganese-bound or free form of the protein, respectively. C, protease K resistance experiment. Dialyzed untreated or 100 μm of manganese chloride-treated Fbp68 were electrophoresed and blotted using Western blot. Parallel samples were treated with increasing concentrations of PK (0, 3.75, 7.5, 15, 30, and 60 ng/μl). Fbp68 was detected using a polyclonal antibody as described under “Materials and Methods.” The experiment was repeated three times.
Interaction of Fbp68 and Fn Requires Manganese
Fbp68 is a Fn-binding protein. To elucidate the effect of manganese on the Fbp68-Fn interaction, histidine-tagged Fbp68 was treated with EDTA and dialyzed in PBS buffer. The binding of Fn to untreated Fbp68 or EDTA-treated Fbp68 with or without Mn2+ was then measured by ELISA. As shown in Fig. 4A, both untreated Fbp68 and Mn2+-bound Fbp68 could associate with Fn with similar affinities (Fbp68, KD = 253 ± 23 nm; Mn2+-bound Fbp68, KD = 221 ± 10 nm). Strikingly, EDTA-treated Fbp68 completely lost Fn binding activity on removal of divalent cation (Fig. 4A). These results clearly indicate that manganese is essential for Fbp68 binding to Fn. The SPR results (Fig. 4, B and C) support the same conclusion because Mn2+-bound Fbp68 was bound tightly to Fn, and EDTA-treated Fbp68 failed to bind to Fn.
Mapping the Fbp68 and NTD-binding Sites
To better define the Fn-binding site of Fbp68, Fbp68 was truncated into two fragments, Fbp68N (residues 2–396) and Fbp68C (residues 397–591) (Fig. 1A). ELISA was performed to determine the interaction of Fn with Fbp68N or Fbp68C. As presented in Fig. 5A, GST-fused Fbp68C was strongly bound to immobilized Fn (KD = 234 ± 22 nm), whereas Fbp68N could not bind. In addition, the Fbp68-binding site on Fn was also mapped via ELISA, and only NTD of Fn was able to interact with GST-fused Fbp68C (KD = 220 ± 93 nm) (Figs. 1B and 5B). ITC and SPR studies yielded similar affinities (ITC, KD = 233 ± 10 nm; SPR, KD = 216 ± 56 nm) (Fig. 5, C and D), providing further support to the Fbp68C-NTD interaction determined by ELISA.
Generating fbp68 Mutant and Complemented Strains
To elucidate physiological roles of the Fbp68-Fn interaction, fbp68 mutant, and fbp68 complemented strains were generated. To obtain fbp68 mutant, the lincomycin-resistant gene was inserted between 102nd and 103rd base pair (Fig. 6A). The transconjugants of C. difficile 630 with the inserted intron would confer a lincomycin-resistant phenotype. To select the fbp68 knock-out mutant, PCR analyses with different primer pairs was performed. As shown in Fig. 6B, 3.6 kb of the DNA fragment could be amplified from the PCR with the primer pairs, Fbp68-F and Fbp68-R, in the selected fbp68 knock-out mutant, but only 1.7-kb PCR amplificon was obtained with the same primer pairs in wild type C. difficile 630 due to the lack of the inserted intron (Fig. 6B). In addition, the 0.9-kb lincomycin-resistant gene was amplified by primer pairs, ErmB-R1 and Thio-F1, and 0.3 kb of 5′ adjacent fragment of inserted intron amplified by Fbp68-F and EBS-Universal primer was observed in this fbp68 knock-out mutant (Fig. 6B). This mutation was complemented in trans with plasmid pMTL84151-fbp68 (Table 1). The immunoblot analysis was also used to demonstrate that Fbp68 was absent in the mutant but restored in the complemented strain (Fig. 6C). This mutation was complemented in trans with plasmid pMTL84151-fbp68 (Table 1).
FIGURE 6.
Generating fbp68 mutant and a complemented strain. A, structure of fbp68 wild type (CD630WT, top) and mutant (CDΔFbp68102, bottom). Oligonucleotide-binding sites used in constructing and screening fbp68 mutant are represented as arrows (fbp68-F, fbp68-R, EBS universal, EmB-R1, Thio-F1; see Table 2). B, PCR analysis of the fbp68 deletion mutant. Lane 1, CDΔFbp68102 (ΔFbp68::Linco®); lane 2, CD630WT (parental strain). The primers used are indicated on the right (see A and Table 2). fliD gene amplified from fliD-F and fliD-R primer pairs served as a positive reference. C, Western blot analysis to detect the expression of fbp68. Samples were immunoblotted using anti-Fbp68 polyclonal antibodies. Lane 1, CD630WT (parental strain); lane 2, CDΔFbp68102 (ΔFbp68::LincoR); lane 3, CDΔFbp68102/pMTL84151-fbp68 (ΔFbp68::LincoR with a plasmid that contains an intact fbp68). All of the lanes contain the protein from 2 × 107 C. difficile 630 cells. The arrow indicates the location of Fbp68.
Treatment of Fbp68C and the Transfection of Fn siRNA Inhibit C. difficile Binding on the Mammalian Cells
Bacterial Fn-binding proteins contribute to host cell adhesion (36, 37, 45). Because Fbp68 is located on the surface of C. difficile (supplemental Fig. 1) (21), it is reasonable to hypothesize that Fbp68 might be one of the adhesins mediating C. difficile adhesion. To gain more understanding of the physiological relevance of Fbp68-Fn interaction, Caco-2 cells, a human epithelial colorectal cell line, were used to test the binding activity of Fbp68C. Compared with GST (negative control), GST-Fbp68C was able to bind to Caco-2 cells as shown in Fig. 7A. In addition, pretreatment of Caco-2 cells with Fbp68C decreased C. difficile adhesion by 51% (Fig. 7, B and C), in agreement with the binding affinity assay results. However, the indistinguishable Fn and cell binding activity of wild type C. difficile 630, fbp68 knock-out mutant, or fbp68 complemented strains suggest redundant adhesins appearing on C. difficile contribute to adhesion (Fig. 7, D and E). To further elucidate the receptor role of Fn on Caco-2 cells for putative binding partners such as Fbp68 of C. difficile, the binding of GST-Fbp68C or C. difficile to Fn or negative siRNA-transfected cells was examined. As shown in Fig. 8A, Fn siRNA duplex specifically reduced the expression of Fn. Moreover, the decreased binding of GST-Fbp68C and a 35% reduction in adhesion of C. difficile to Fn siRNA-transfected cells (compared with the negative siRNA transfected cells) validated the conclusion that Fn plays a pivotal role in the adherence of C. difficile (Fig. 8B) (data not shown).
FIGURE 8.
Binding of Fbp68C to Fn siRNA transfected Caco-2 cells was reduced. A, detection of the expression of Fn and actin in Caco-2 cells 72 h after transfection with Fn or negative siRNA. Fn and α-actin were detected on immunoblots probed by actin or Fn antibodies. B, binding of GST-Fbp68C was reduced in siRNA transfected cells. C, 50 μm of GST-Fbp68C or GST (negative control) was added to Fn or negative siRNA-transfected Caco-2 cells. Expression of Fn and the binding of these proteins to Caco-2 cells were detected by CLSM. The CLSM settings were identical for all the captured images. Images were processed using Adobe Photoshop CS2.
DISCUSSION
Two high molecular weight toxins (toxins A and B) of C. difficile play major roles in the pathogenesis of pseudomembranous colitis and antibiotic-associated diarrhea (1). However, not all C. difficile-associated disease is caused by toxigenic strains of C. difficile (5, 8, 14, 46, 47). Thus, other virulence factors, such as adhesins, are likely important in the pathogenesis of C. difficile-associated disease. Adhesion is a crucial first step that allows pathogenic bacteria, including C. difficile, to infect host cells. A group of virulence factors, MSCRAMMs, mediates adhesion of a wide variety of pathogenic bacteria, including Staphylococcus, Streptococcus, Enterococcus, Borrelia, Leptospira, and others (19, 26, 34, 35, 37, 48, 49). Generally, MSCRAMMs are located on the outer surface of bacteria thereby mediating attachment to host cells by interacting with fibrinogen or various ECM components such as Fn, laminin, collagen, elastin, and proteoglycan (19). A number of C. difficile MSCRAMMs that bind to either host cells or various ECM components have been described and include Fbp68 (11), SlpA (4), Cwp66 (14), and 27-kDa protein (50). These adhesins may be significant factors in the virulence of different C. difficile strains.
Numerous studies indicate that at least some MSCRAMMs, such as LipL32 and Lig proteins of L. interrogans and ClfA of Staphylococcus aureus, are metalloproteins (26, 27, 41, 51) In this study, we demonstrated that Fbp68 is a manganese-binding protein and also showed that it binds to manganese with high affinity and specificity (KD = 52 ± 1.97 nm). This is the first study to identify a bacterial manganese binding MSCRAMM. Because a higher concentration of free manganese would be an oxidative stress in the cells (52), the concentration of free manganese in vivo is extremely low (10−7 m) (53). In addition, manganese is a trace element and is present at very low levels in the environment (10−7 m) (52). To acquire environmental manganese, the binding affinity of most manganese-binding proteins must be high (e.g. E. coli manganese superoxide dismutase, KD = 3.12 nm) (44). Thus, the high affinity of Fbp68 for manganese would help overcome the low concentration of manganese both in vivo and in the environment. Most metalloproteins undergo conformational changes upon metal ion binding. In certain extreme cases, apo-metalloproteins lose their conformation because metal ions stabilize the structure (54). In other cases, the geometry of the metal ion-binding sites is dominated by metalloproteins so the structure of apoproteins is able to be maintained although partial alteration of the conformation is still observed upon metal ion binding (55). Manganese binding changed the global conformation of Fbp68, but the structure of apo-Fbp68 can still be discerned in far-UV spectra. Thus, our results suggest that Fbp68 dominates the geometry of the manganese binding region.
Manganese usually enhances protein structural stability. For example, when manganese binds to manganese superoxide dismutase of E. coli, the protein structure is stabilized as evidenced by the increased Tm of manganese-bound proteins in thermo-unfolding experiments (apo-superoxide dismutase, Tm = 52.5 °C; manganese superoxide dismutase, Tm = 68.6 °C) (44). Likewise, manganese-bound prion protein resists higher concentrations of protease K, which also indicates the protein structure is stabilized by manganese (apo-prion, protease K = 2 μg/ml; manganese prion, protease K >25 μg/ml) (43). In this study, the dramatically increased Tm and the significantly decreased susceptibly of manganese-bound Fbp68 to protease K suggests that manganese binding stabilizes the structure of Fbp68, similar to other manganese-binding proteins. Enhanced Fbp68 stability upon manganese binding may aid C. difficile survival by preventing protease digestion, thereby providing a competitive advantage over other bacteria in maintaining a foothold in a highly competitive environment such as the gut.
Several recent studies show that metal ions modulate the functions of bacterial adhesins. Reportedly, calcium binding enhanced but was not essential for the Fn binding activities of LipL32 and Lig proteins from L. interrogans (26, 27, 41). However, ClfA binding to calcium reduces its fibrinogen binding affinity (51). Interestingly, we discovered that manganese not only improved Fbp68 binding to Fn but was required for Fn binding to Fbp68. Our results suggest that the mechanism by which manganese promotes the binding of clostridial Fbp68 to Fn differs from that of calcium bound to leptospiral LipL32 or Lig proteins. It is believed that metal ion binding dominates protein-protein interactions through several different mechanisms. In some cases, metal ion binding causes a conformational change, and the binding partner is able to selectively and specifically bind to holoproteins instead of apoproteins. A global structural transition was observed in Fbp68 upon manganese binding, which suggests a conformational change mediated the ability of Fbp68 to bind to Fn in the presence of manganese. Alternatively, metal ions can serve as a bridge to link a protein to its binding partner. For example, the general metal ion-dependent adhesion site on the α-subunit of integrin CR3 coordinates magnesium or manganese binding to its binding partners (56). However, Fn binding is entirely dependent upon the manganese within Fbp68, and Fbp68 lacks affinity for magnesium. Thus, manganese might form a cross-link between Fbp68 and Fn, but the binding motif should be different from the metal ion-dependent adhesion site of the α-subunit of integrin. As shown in Fig. 2 and Table 3, the stoichiometry of manganese binding to Fbp68 is five. Because Fbp68 possesses eight degenerated repeated sequences (11), it is possible that the manganese-binding motif of Fbp68 is located in these degenerated repeated sequences. However, an attempt to correlate these repeated amino acid sequences of Fbp68 with other known manganese-binding motifs was unsuccessful Thus, Fbp68 may utilize a novel manganese-binding motif.
C. difficile Fbp68 possesses high sequence similarity with other known Fn-binding proteins including Fbp54 of Streptococcus pyogenes (39% identity), PavA of Streptococcus pneumoniae (38% identity), FbpA of Streptococcus gordonii (30% identity), and Fbp of Bacillus subtilis (44% identity) (11, 57–59). The Fn binding region was mapped to the C-terminal 189 amino acids of PavA based on binding inhibition of full-length PavA or S. pneumoniae to immobilized Fn by truncated PavA without the C-terminal 189 amino acids (59). Similarly, Fn can only bind to Fbp68C, the C-terminal 194 amino acids, which show 42% sequence homology to the Fn binding region of PavA. Furthermore, the binding site for Fbp68 on Fn was localized to NTD, the heparin binding domain of Fn, consistent with PavA and Fbp54 (59). Taken together, it is likely that the mechanism of binding of PavA, Fbp54, and Fbp68 to Fn is similar. Recently, it was proposed that a group of similar NTD-binding motifs on diversified bacterial proteins such as FnbpA and FnbpB of S. aureus, FnBB of Streptococcus dysgalactiae, SfbI of S. pyogenes, and BBK32 of Borrelia burgdorferi possess a general binding mechanism called tandem β-zipper for bacterial MSCRAMMs binding to NTD (49, 60–63). On the other hand, two NTD binding regions, unique Fn binding domain (UFbD) and repeated Fn binding domain (FbRD), were identified in Streptococcus PrtF1 and PrtF2 proteins (64). Neither of these Fn binding domains has sequence similarity with Fbp68, Fbp54, or PavA (data not shown). Thus, it is highly probable that Fbp68, Fbp54, and PavA possess a conserved but novel NTD-binding motif that utilizes an as yet undetermined Fn-binding mechanism.
ECM binding, including Fn binding, is regularly elicited by pathogens to adhere to host cells (19, 48, 65). Moreover, Fn can also serve as a mediator to induce endocytosis and initiate the entry of bacteria when it binds to bacterial Fn-binding proteins (65, 66). Thus, the Caco-2 cell binding activity of Fbp68 and the reduced binding effects of C. difficile in Fbp68 or Fn siRNA treated Caco-2 cells suggest an adhesive role for Fbp68. However, the fbp68 knock-out mutant showed similar cell and Fn binding activities compared with wild type C. difficile 630, strongly suggesting multiple adhesins are present on the surface of C. difficile with redundant adhesive properties (5, 10–11, 13–15). Furthermore, because C. difficile is not an intracellular pathogen, the rationale for C. difficile to bind to Fn is unlikely to be related to invasion as is the case for other bacteria. It was reported that the toxin of C. difficile could be digested by certain proteases in the cecum of mice (67) so adhesion of C. difficile may be able to target the toxin to the cell, thereby increasing toxin concentration at the cell surface and avoiding proteolysis, which would enhance toxin efficacy. On the other hand, another adhesin of C. difficile, SlpA, binds to ECM components and causes further epithelial damage following toxin-induced destruction of tissue (4). It has also been observed that the adherence of C. difficile to Caco-2 cells is enhanced through the addition of clostridial C. difficile transferase toxin (68). It is reasonable to hypothesize that Fbp68 and other adhesins of C. difficile might bind to ECM receptors that have been unmasked by tissue injury, resulting in more severe damage in the intestine and colon. Thus, clostridial toxins and adhesins may act synergistically in the pathogenesis of C. difficile-associated disease.
In conclusion, we have demonstrated that Fbp68 is a manganese-binding protein, manganese binding stabilizes the structure of Fbp68, and that Fbp68 binds to the NTD of Fn. In addition, this is the first study to identify a manganese-binding adhesin for Fn. Further studies to identify the binding motifs and define the mechanisms of Fn and manganese interaction with Fbp68 are ongoing in our laboratory.
Supplementary Material
Acknowledgments
We thank Charlene Mottler for help with ITC; Dr. Richard Medville for assistance with electron microscopy; Drs. Moonsoo Jin and Marci Scidmore for kindly allowing us to use their surface plasmon resonance and confocal laser scanning microscope, respectively; Dr. John Heap for advice regarding the construction of C. difficile mutants; and Peter R. Harpending for technical assistance. We also thank Dr. Nigel Minton for the gifts of plasmids (pMTL007-E2 and PMTL84151) and Dr. Mark McBride for the gift of E. coli CA434.
This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30054, Project ZC005-06 and ZC008-09 from NIAID, Department of Health and Human Services.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.
- MSCRAMM
- microbial surface component recognizing adhesive matrix molecule
- CLSM
- confocal laser scanning microscopy
- DSC
- differential scanning calorimetry
- ECM
- extracellular matrix
- ITC
- isothermal titration calorimetry
- NTD
- N-terminal domain
- SPR
- surface plasmon resonance
- CBD
- cell binding domain
- Fn
- fibronectin
- ANS
- anilinonaphthalene sulfonic acid
- Ni-NTA
- nickel-nitrilotriacetic acid.
REFERENCES
- 1. Kelly C. P., LaMont J. T. (1998) Annu. Rev. Med. 49, 375–390 [DOI] [PubMed] [Google Scholar]
- 2. McDonald L. C., Killgore G. E., Thompson A., Owens R. C., Jr., Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N. (2005) N. Engl. J. Med. 353, 2433–2441 [DOI] [PubMed] [Google Scholar]
- 3. Giesemann T., Egerer M., Jank T., Aktories K. (2008) J. Med. Microbiol. 57, 690–696 [DOI] [PubMed] [Google Scholar]
- 4. Calabi E., Calabi F., Phillips A. D., Fairweather N. F. (2002) Infect. Immun. 70, 5770–5778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Eveillard M., Fourel V., Barc M. C., Kernéis S., Coconnier M. H., Karjalainen T., Bourlioux P., Servin A. L. (1993) Mol. Microbiol. 7, 371–381 [DOI] [PubMed] [Google Scholar]
- 6. Davies H. A., Borriello S. P. (1990) Microb. Pathog. 9, 141–146 [DOI] [PubMed] [Google Scholar]
- 7. Poilane I., Karjalainen T., Barc M. C., Bourlioux P., Collignon A. (1998) Can. J. Microbiol. 44, 157–161 [PubMed] [Google Scholar]
- 8. Seddon S. V., Borriello S. P. (1992) J. Med. Microbiol. 36, 307–311 [DOI] [PubMed] [Google Scholar]
- 9. Calabi E., Ward S., Wren B., Paxton T., Panico M., Morris H., Dell A., Dougan G., Fairweather N. (2001) Mol. Microbiol. 40, 1187–1199 [DOI] [PubMed] [Google Scholar]
- 10. Cerquetti M., Molinari A., Sebastianelli A., Diociaiuti M., Petruzzelli R., Capo C., Mastrantonio P. (2000) Microb. Pathog. 28, 363–372 [DOI] [PubMed] [Google Scholar]
- 11. Hennequin C., Janoir C., Barc M. C., Collignon A., Karjalainen T. (2003) Microbiology 149, 2779–2787 [DOI] [PubMed] [Google Scholar]
- 12. Karjalainen T., Waligora-Dupriet A. J., Cerquetti M., Spigaglia P., Maggioni A., Mauri P., Mastrantonio P. (2001) Infect. Immun. 69, 3442–3446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Karjalainen T., Saumier N., Barc M. C., Delmée M., Collignon A. (2002) J. Clin. Microbiol. 40, 2452–2458 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Waligora A. J., Hennequin C., Mullany P., Bourlioux P., Collignon A., Karjalainen T. (2001) Infect. Immun. 69, 2144–2153 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Tasteyre A., Karjalainen T., Avesani V., Delmée M., Collignon A., Bourlioux P., Barc M. C. (2001) J. Clin. Microbiol. 39, 1178–1183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Tasteyre A., Barc M. C., Collignon A., Boureau H., Karjalainen T. (2001) Infect. Immun. 69, 7937–7940 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hennequin C., Porcheray F., Waligora-Dupriet A., Collignon A., Barc M., Bourlioux P., Karjalainen T. (2001) Microbiology 147, 87–96 [DOI] [PubMed] [Google Scholar]
- 18. Hennequin C., Collignon A., Karjalainen T. (2001) Microb. Pathog. 31, 255–260 [DOI] [PubMed] [Google Scholar]
- 19. Patti J. M., Allen B. L., McGavin M. J., Höök M. (1994) Annu. Rev. Microbiol. 48, 585–617 [DOI] [PubMed] [Google Scholar]
- 20. Seshu J., Esteve-Gassent M. D., Labandeira-Rey M., Kim J. H., Trzeciakowski J. P., Höök M., Skare J. T. (2006) Mol. Microbiol. 59, 1591–1601 [DOI] [PubMed] [Google Scholar]
- 21. Papp-Wallace K. M., Maguire M. E. (2006) Annu. Rev. Microbiol. 60, 187–209 [DOI] [PubMed] [Google Scholar]
- 22. Ainsworth S., Macfarlane N. (1975) Biochem. J. 145, 63–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Shi L., Kehres D. G., Maguire M. E. (2001) J. Bacteriol. 183, 7053–7057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Santos R., Franza T., Laporte M. L., Sauvage C., Touati D., Expert D. (2001) Mol. Plant Microbe Interact. 14, 758–767 [DOI] [PubMed] [Google Scholar]
- 25. Johnson G. S., Adler C. R., Collins J. J., Court D. (1979) J. Biol. Chem. 254, 5483–5487 [PubMed] [Google Scholar]
- 26. Lin Y. P., Raman R., Sharma Y., Chang Y. F. (2008) J. Biol. Chem. 283, 25140–25149 [DOI] [PubMed] [Google Scholar]
- 27. Tung J. Y., Yang C. W., Chou S. W., Lin C. C., Sun Y. J. (2010) J. Biol. Chem. 285, 3245–3252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Péchiné S., Gleizes A., Janoir C., Gorges-Kergot R., Barc M. C., Delmée M., Collignon A. (2005) J. Med. Microbiol. 54, 193–196 [DOI] [PubMed] [Google Scholar]
- 29. Janvilisri T., Scaria J., Thompson A. D., Nicholson A., Limbago B. M., Arroyo L. G., Songer J. G., Gröhn Y. T., Chang Y. F. (2009) J. Bacteriol. 191, 3881–3891 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Janvilisri T., Scaria J., Chang Y. F. (2010) J. Infect. Dis. 202, 282–290 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Heap J. T., Kuehne S. A., Ehsaan M., Cartman S. T., Cooksley C. M., Scott J. C., Minton N. P. (2010) J. Microbiol. Methods 80, 49–55 [DOI] [PubMed] [Google Scholar]
- 32. Heap J. T., Pennington O. J., Cartman S. T., Carter G. P., Minton N. P. (2007) J. Microbiol. Methods 70, 452–464 [DOI] [PubMed] [Google Scholar]
- 33. Heap J. T., Pennington O. J., Cartman S. T., Minton N. P. (2009) J. Microbiol. Methods 78, 79–85 [DOI] [PubMed] [Google Scholar]
- 34. Lin Y. P., Lee D. W., McDonough S. P., Nicholson L. K., Sharma Y., Chang Y. F. (2009) J. Biol. Chem. 284, 19380–19391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Lin Y. P., Greenwood A., Nicholson L. K., Sharma Y., McDonough S. P., Chang Y. F. (2009) J. Biol. Chem. 284, 23547–23557 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Lin Y. P., Chang Y. F. (2007) Biochem. Biophys. Res. Commun. 362, 443–448 [DOI] [PubMed] [Google Scholar]
- 37. Lin Y. P., Chang Y. F. (2008) J. Vet. Sci. 9, 133–144 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chessa D., Winter M. G., Nuccio S. P., Tükel C., Bäumler A. J. (2008) Mol. Microbiol. 68, 573–587 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Vendrame F., Segni M., Grassetti D., Tellone V., Augello G., Trischitta V., Torlontano M., Dotta F. (2006) J. Clin. Endocrinol. Metabol. 91, 5064–5068 [DOI] [PubMed] [Google Scholar]
- 40. Dugan T. A., Yang V. W., McQuillan D. J., Höök M. (2003) J. Biol. Chem. 278, 13655–13662 [DOI] [PubMed] [Google Scholar]
- 41. Hauk P., Guzzo C. R., Roman, Ramos H., Ho P. L., Farah C. S. (2009) J. Mol. Biol. 390, 722–736 [DOI] [PubMed] [Google Scholar]
- 42. Mould A. P., Akiyama S. K., Humphries M. J. (1995) J. Biol. Chem. 270, 26270–26277 [DOI] [PubMed] [Google Scholar]
- 43. Brown D. R., Hafiz F., Glasssmith L. L., Wong B. S., Jones I. M., Clive C., Haswell S. J. (2000) EMBO J. 19, 1180–1186 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Mizuno K., Whittaker M. M., Bächinger H. P., Whittaker J. W. (2004) J. Biol. Chem. 279, 27339–27344 [DOI] [PubMed] [Google Scholar]
- 45. Coburn J., Fischer J. R., Leong J. M. (2005) Mol. Microbiol. 57, 1182–1195 [DOI] [PubMed] [Google Scholar]
- 46. Borriello S. P., Davies H. A., Kamiya S., Reed P. J., Seddon S. (1990) Rev. Infect. Dis. 12, S185–S191 [DOI] [PubMed] [Google Scholar]
- 47. Tasteyre A., Barc M. C., Karjalainen T., Dodson P., Hyde S., Bourlioux P., Borriello P. (2000) Microbiology 146, 957–966 [DOI] [PubMed] [Google Scholar]
- 48. Schwarz-Linek U., Höök M., Potts J. R. (2004) Mol. Microbiol. 52, 631–641 [DOI] [PubMed] [Google Scholar]
- 49. Schwarz-Linek U., Pilka E. S., Pickford A. R., Kim J. H., Höök M., Campbell I. D., Potts J. R. (2004) J. Biol. Chem. 279, 39017–39025 [DOI] [PubMed] [Google Scholar]
- 50. Karjalainen T., Barc M. C., Collignon A., Trollé S., Boureau H., Cotte-Laffitte J., Bourlioux P. (1994) Infect. Immun. 62, 4347–4355 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. O'Connell D. P., Nanavaty T., McDevitt D., Gurusiddappa S., Höök M., Foster T. J. (1998) J. Biol. Chem. 273, 6821–6829 [DOI] [PubMed] [Google Scholar]
- 52. Silva J. J., Williams R. J. (eds) (2001) The Biological Chemistry of the Elements: The Inorganic Chemistry of Life, 2nd Ed., pp. 402–407, Oxford University Press, Oxford [Google Scholar]
- 53. Hesketh S., Sassoon J., Knight R., Brown D. R. (2008) Mol. Cell. Neurosci. 37, 590–598 [DOI] [PubMed] [Google Scholar]
- 54. Barondeau D. P., Getzoff E. D. (2004) Curr. Opin. Struct. Biol. 14, 765–774 [DOI] [PubMed] [Google Scholar]
- 55. Tainer J. A., Getzoff E. D., Richardson J. S., Richardson D. C. (1983) Nature 306, 284–287 [DOI] [PubMed] [Google Scholar]
- 56. Lee J. O., Rieu P., Arnaout M. A., Liddington R. (1995) Cell 80, 631–638 [DOI] [PubMed] [Google Scholar]
- 57. Christie J., McNab R., Jenkinson H. F. (2002) Microbiology 148, 1615–1625 [DOI] [PubMed] [Google Scholar]
- 58. Courtney H. S., Dale J. B., Hasty D. I. (1996) Infect. Immun. 64, 2415–2419 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Holmes A. R., McNab R., Millsap K. W., Rohde M., Hammerschmidt S., Mawdsley J. L., Jenkinson H. F. (2001) Mol. Microbiol. 41, 1395–1408 [DOI] [PubMed] [Google Scholar]
- 60. Bingham R. J., Rudiño-Piñera E., Meenan N. A., Schwarz-Linek U., Turkenburg J. P., Höök M., Garman E. F., Potts J. R. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 12254–12258 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Meenan N. A., Visai L., Valtulina V., Schwarz-Linek U., Norris N. C., Gurusiddappa S., Höök M., Speziale P., Potts J. R. (2007) J. Biol. Chem. 282, 25893–25902 [DOI] [PubMed] [Google Scholar]
- 62. Raibaud S., Schwarz-Linek U., Kim J. H., Jenkins H. T., Baines E. R., Gurusiddappa S., Höök M., Potts J. R. (2005) J. Biol. Chem. 280, 18803–18809 [DOI] [PubMed] [Google Scholar]
- 63. Schwarz-Linek U., Werner J. M., Pickford A. R., Gurusiddappa S., Kim J. H., Pilka E. S., Briggs J. A., Gough T. S., Höök M., Campbell I. D., Potts J. R. (2003) Nature 423, 177–181 [DOI] [PubMed] [Google Scholar]
- 64. Jaffe J., Natanson-Yaron S., Caparon M. G., Hanski E. (1996) Mol. Microbiol. 21, 373–384 [DOI] [PubMed] [Google Scholar]
- 65. Peacock S. J., Foster T. J., Cameron B. J., Berendt A. R. (1999) Microbiology 145, 3477–3486 [DOI] [PubMed] [Google Scholar]
- 66. Mempel M., Schnopp C., Hojka M., Fesq H., Weidinger S., Schaller M., Korting H. C., Ring J., Abeck D. (2002) Br. J. Dermatol. 146, 943–951 [DOI] [PubMed] [Google Scholar]
- 67. Corthier G., Muller M. C., Elmer G. W., Lucas F., Dubos-Ramaré F. (1989) Infect. Immun. 57, 3922–3927 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Schwan C., Stecher B., Tzivelekidis T., van Ham M., Rohde M., Hardt W. D., Wehland J., Aktories K. (2009) PLoS Pathog. 5, e1000626. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.








